The annual Genesis Prize, referred to as the “Jewish Nobel Prize”, is awarded to outstanding individuals for their exceptional professional achievements, contribution to the development of human civilization, commitment to Jewish values and the State of Israel.
This year, the solemn ceremony of awarding the “Jewish Nobel Prize”, which took place on June 29 in Jerusalem, was attended by the Chairman of the Jewish Community of the Republic of Moldova, Alexander Bilinkis, representatives of the Jewish Diaspora and the world medical community.
Dr. Albert Burla, Chief Executive Officer of Pfizer, was announced as the ninth recipient of the Genesis Award in January 2022. Burla received one of the most prestigious awards in the Jewish world for his contribution to the development of a vaccine against COVID-19, which saved millions of human lives. The award also recognized the laureate’s commitment to Jewish identity and his support for the State of Israel.
“I am honored to receive this award and I accept it with humility,” said Genesis Prize winner Dr. Albert Burla at a ceremony in Jerusalem. “This award goes to the entire Pfizer team who have worked tirelessly during the height of the pandemic to make the “impossible possible” and give the world a chance to get back to normal. Every life is precious and we must face the next challenges to humanity with courage and determination.”
Speaking at the ceremony, Dr. Burla officially announced that he would donate the $1 million he received from the award to support the Greek Museum of the Holocaust in Thessaloniki.